[2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand].
Sugiura
Takayuki
T
Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Sagamihara, Kanagawa 229-0195, Japan.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism / Q000502:physiology*; D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D004075:Diglycerides / Q000502:physiology; D063388:Endocannabinoids; D005989:Glycerides / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D007107:Immune System / Q000276:immunology; D007249:Inflammation / Q000209:etiology; D008024:Ligands; D009129:Muscle Tonus; D009131:Muscle, Smooth, Vascular; D010716:Phosphatidylinositols / Q000378:metabolism; D011493:Protein Kinase C / Q000502:physiology; D043882:Receptors, Cannabinoid / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction
D001095:Arachidonic Acids; D063386:Cannabinoid Receptor Agonists; D063387:Cannabinoid Receptor Antagonists; D004075:Diglycerides; D063388:Endocannabinoids; D005989:Glycerides; D008024:Ligands; D010716:Phosphatidylinositols; D043882:Receptors, Cannabinoid; C094503:glyceryl 2-arachidonate; D011493:Protein Kinase C